| CTRI Number |
CTRI/2022/01/039613 [Registered on: 20/01/2022] Trial Registered Prospectively |
| Last Modified On: |
21/01/2022 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Process of Care Changes |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
BREAST MILK FOR PAIN RELIEF DURING ECHOCARDIOGRAPHY IN NEONATES |
|
Scientific Title of Study
|
STUDY OF BREAST MILK FOR PAIN RELIEF DURING TARGETED NEONATAL ECHOCARDIOGRAPHY |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
DR PRAMEETA R CHIGARI |
| Designation |
IAP FELLOW IN NEONATOLOGY |
| Affiliation |
LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL |
| Address |
DEPARTMENT OF NEONATOLOGY LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL SION WEST MUMBAI,400022
Mumbai MAHARASHTRA 400022 India |
| Phone |
8904848504 |
| Fax |
|
| Email |
drpramitarc1@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR SWATI MANERKAR |
| Designation |
HEAD OF DEPARTMENT |
| Affiliation |
LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL |
| Address |
DEPARTMENT OF NEONATOLOGY LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL SION WEST MUMBAI,400022
Mumbai MAHARASHTRA 400022 India |
| Phone |
9769997968 |
| Fax |
|
| Email |
drswatimanerkar@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
DR PRAMEETA R CHIGARI |
| Designation |
IAP FELLOW IN NEONATOLOGY |
| Affiliation |
LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL |
| Address |
DEPARTMENT OF NEONATOLOGY LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL SION WEST MUMBAI,400022
Mumbai MAHARASHTRA 400022 India |
| Phone |
8904848504 |
| Fax |
|
| Email |
drpramitarc1@gmail.com |
|
|
Source of Monetary or Material Support
|
| LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL,MUMBAI |
|
|
Primary Sponsor
|
| Name |
LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITALMUMBAI |
| Address |
LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL, SION,MUMBAI,MAHARASHTRA 400022 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR SWATI MANERKAR |
LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL |
DEPARTMENT OF NEONATOLOGY,ROOM NO 123,FIRST FLOOR,COLLEGE BUILDING,LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL,MUMBAI Mumbai MAHARASHTRA |
9769997968
drswatimanerkar@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL ETHICS COMMITTEE HUMAN RESEARCH LOKMANYA TILAK MUNICIPAL COLLEGE AND GENERAL HOSPITAL |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: P84||Other problems with newborn, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
EXPRESSED BREAST MILK |
NEONATES UNDERGOING TARGETED NEONATAL ECHOCARDIOGRAPHY WILL BE RANDOMISED TO INTERVENTIONAL GROUP AND COMPARATOR GROUP. BABIES RANDOMISED TO INTERVENTION GROUP WILL RECEIVE 1ML/KG OF EXPRESSED BREAST MILK WHICH WILL BE SWABBED OVER THE BUCCAL MUCOSA 10 MINUTES PRIOR TO UNDERGOING ECHOCARDIOGRAPHY. |
| Comparator Agent |
NO INTERVENTION |
NO INTERVENTION |
|
|
Inclusion Criteria
|
| Age From |
1.00 Day(s) |
| Age To |
28.00 Day(s) |
| Gender |
Both |
| Details |
All VLBW babies undergoing Tn-ECHO according to NICU protocol.All VLBW babies undergoing Tn-ECHO according to NICU protocol. |
|
| ExclusionCriteria |
| Details |
1. Severe perinatal asphyxia
2. Neonatal encephalopathy
3. Major congenital malformation
4. Babies on drugs causing CNS depression
|
|
|
Method of Generating Random Sequence
|
Permuted block randomization, variable |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Comparison of PIPP-R scores between the two study group |
Comparison of PIPP-R scores between the two study groups 5 minutes before, during and 5 minutes after echocardiography |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Heart rate |
Comparison of heart rate between the two study groups 5 minutes before, during and 5 minutes after echocardiography |
| Respiratory rate |
Comparison of respiratory rate between the two study groups 5 minutes before, during and 5 minutes after echocardiography |
| Blood pressure |
Comparison of blood pressure between the two study groups 5 minutes before and 5 minutes after echocardiography |
| Perfusion index |
Comparison of perfusion index between the two study groups 5 minutes before, during and 5 minutes after echocardiography |
|
|
Target Sample Size
|
Total Sample Size="34" Sample Size from India="34"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
25/01/2021 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Open to Recruitment |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
nil |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This randomised controlled trial will be conducted on VLBW babies admitted in our unit & undergoing Tn-ECHO. The study will commence after approval from Institutional Ethics Committee (IEC). The decision to do Tn-ECHO will be taken by the NICU team, according to institution protocols based on the the standard of care. Those babies satisfying the inclusion criteria will be enrolled after written informed consent from either parent. Babies will be randomized to receive either expressed breast milk (Group A) or no intervention (Group B). Blocked randomization will be done using computer generated random number sequencing using block sizes of 2 & 4. Allocation concealment will be done using serially numbered opaque sealed envelopes. Procedure: Tn-ECHO examination will be done by senior neonatologist trained in basic neonatal ECHO. Sonosite Fujifilm 2D-ECHO machine will be used. Before examination all the noxious stimuli will be minimized. Babies in both groups will receive non pharmacological pain relief intervention in form of containment and facilitated tucking. Alarms of all equipments will be minimized. All subjects will be evaluated 5 minutes before Tn-ECHO for PIPP-R score & physiological parameters like HR, RR, spO2, PI (heart rate, respiratory rate, blood pressure, transcutaneous oxygen saturation, perfusion index) will be recorded. For behavioral components of PIPP-R score video recording will be done using a smart phone. Babies in Group A WILL RECEIVE 1ML/KG OF EXPRESSED BREAST MILK WHICH WILL BE SWABBED OVER THE BUCCAL MUCOSA. Babies randomized to Group B will receive no additional intervention. PIPP-R score & other physiological parameters will be recorded during the examination and 5 minutes after completion of Tn-echo examination. Behavioral score component of PIPP-R will be interpreted from the video recording by two independent neonatologists who will be blinded to the intervention. Table 1: Physiological parameters of newborn related to tn-ECHO examination | | 5 mins Before examination | During examination | 5 mins after examination | | HR (per min) | | | | | RR (per min) | | | | | Spo2 (%) | | | | | PI | | | | | SBP (mmHg) | | × | | | DBP (mmHg) | | × | | | MAP( mmHg) | | × | | HR: Heart Rate, RR: Respiratory Rate, Spo2: Transcutaneous oxygen saturation pre-ductal, PI: Perfusion Index, SBP: systolic Blood Pressure, DBP: Diastolic Blood Pressure, MAP: Mean Arterial Pressure. PIPP-R scoring figure taken from 2013 Lippincott Williams & Wilkins. |